Severe Asthma Digital Marketing Trends Report 2022 Featuring Sanofi, Regeneron, Genentech, Novartis, GSK, AstraZeneca, Amgen, & Teva

Severe Asthma Digital Marketing Trends Report 2022 Featuring Sanofi, Regeneron, Genentech, Novartis, GSK, AstraZeneca, Amgen, & Teva

DUBLIN, Nov. 21, 2022 /PRNewswire/ — The “Digital Marketing Trends in Severe Asthma” report has been added to┬áResearchAndMarkets.com’s offering.

Research and Markets Logo

Sanofi/Regeneron’s Dupixent.com achieved the highest traffic across branded severe asthma patient sites in the US from July 2021 to June 2022, with about 7,800,000 visits, followed by Novartis’ Xolair.com, and GSK’s Nucala.com.

The highest proportion of traffic to these sites originated from direct sources, followed by…


Source link

About seo

Check Also

Ecommerce Product Releases: February 1, 2023

Ecommerce Product Releases: February 1, 2023

Here is a list of product releases and updates for late January from companies that …

Leave a Reply

Your email address will not be published. Required fields are marked *